R. Polosa (S. Gregorio, Italy), L. Bjermer (Lund, Sweden)
Gene expression profiling identifies neutrophilic and eosinophilic asthma as distinct subtypes
P. G. Gibson, K. J. Baines, J. L. Simpson, R. J. Scott (NSW, Australia)
|  |
Alternative criteria to evaluate reversibility of airflow obstruction in severe asthma
C. Thorette, I. Tillie-Leblond, S. Pouwels-fry, V. Debroucker, A. B. Tonnel, T. Perez (Lille, France)
| |
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
R. Middelveld, S. E. Dahlén (Stockholm, Sweden)
|   |
Increased urinary LTE4 in severe asthma and COPD: interim report from the BIOAIR study
On behalf of the BIOAIR study group, I. Delin, M. Kumlin, S. E. Dahlén (Stockholm, Sweden)
| |
Obesity and the response to inhaled budesonide in patients with asthma
E. Heffler, R. Green, C. Brightling, I. Pavord (Torino, Italy; Leicester, United Kingdom)
| |
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness
E. Tufvesson, D. Aronsson, L. Bjermer (Lund, Sweden)
| |
Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum
H. Matsuoka, A. Niimi, H. Matsumoto, T. Ueda, M. Takemura, M. Yamaguchi, M. Jinnai, K. Otsuka, T. Oguma, T. Takeda, M. Mishima (Kyoto, Japan)
| |